Widespread Treponema pallidum Infection in Nonhuman Primates, Tanzania by Chuma, IS et al.
We investigated Treponema pallidum infection in 8 nonhu-
man primate species (289 animals) in Tanzania during 2015–
2017. We used a serologic treponemal test to detect anti-
bodies against the bacterium. Infection was further confirmed 
from tissue samples of skin-ulcerated animals by 3 indepen-
dent PCRs (polA, tp47, and TP_0619). Our findings indicate 
that T. pallidum infection is geographically widespread in 
Tanzania and occurs in several species (olive baboons, yel-
low baboons, vervet monkeys, and blue monkeys). We found 
the bacterium at 11 of 14 investigated geographic locations. 
Anogenital ulceration was the most common clinical manifes-
tation; orofacial lesions also were observed. Molecular data 
show that nonhuman primates in Tanzania are most likely 
infected with T. pallidum subsp. pertenue–like strains, which 
could have implications for human yaws eradication.
The geographic distribution of infection with the bac-terium Treponema pallidum in nonhuman primates 
(NHPs) in Africa has been reported to closely match the 
one seen in human yaws in Africa before the first yaws 
eradication campaign (1). Some Africa countries, such as 
Tanzania, have a history of human yaws but lack recent 
epidemiologic data that support elimination (2). At the 
same time, many of these countries report NHP infection 
with T. pallidum strains that are highly similar to the hu-
man yaws–causing T. pallidum subsp. pertenue (TPE) (3,4; 
S. Knauf et al., unpub. data, https://www.biorxiv.org/ 
content/early/2017/05/10/135491) and thus make NHP in-
fection an important issue for a One Health approach.
The first published report of T. pallidum infection in 
Tanzanian NHPs came from anogenital ulcerated olive 
baboons (Papio anubis) at Gombe National Park (GNP) 
in the late 1980s (5), followed by cases reported from 
olive baboons at Lake Manyara National Park (LMNP) 
(3,6,7) and Serengeti National Park (SNP) (3). Clinical 
manifestations of T. pallidum infection in NHPs ranged 
from asymptomatic to severe skin ulceration mainly af-
fecting the face or genitalia (8). Although early serologic 
investigations conducted by Fribourg-Blanc in West Af-
rica confirmed widespread infection in several NHP spe-
cies (e.g., baboons [Papio sp.], guenons [Cercopithecus 
sp.], red colobus [Piliocolobus badius], and chimpan-
zees [Pan trogoldytes]) (9), the infection in Tanzania 
was exclusively reported from olive baboons in northern 
parts of the country. Despite the close genetic relation-
ship to human yaws–causing TPE strains (3,4; S. Knauf 
et al., unpub. data, https://www.biorxiv.org/content/
early/2017/05/10/135491), and in the absence of recent 
reports of human yaws in Tanzania (10), it is currently 
unclear whether NHP strains naturally infect humans.
As a starting point and basis for advanced epidemio-
logic investigations, our main objective was to investigate 
the geographic distribution and host species composition of 
T. pallidum infection in free-ranging NHPs in Tanzania. We 
hypothesized that, in Tanzania, A) NHPs other than olive 
baboons are infected with the T. pallidum bacterium and B) 
that infection is not restricted to northern parts of the country.
Materials and Methods
Study Design, Sampling Sites, and Animals
We applied a cross-sectional study design using semiran-
dom selection of free-ranging NHPs in selected areas in 
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Tanzania. Selection of NHPs was biased toward animals 
with visible skin ulcers. Sampling took place at Arusha 
National Park (ANP), GNP, Katavi NP (KNP), LMNP, 
Mahale NP (MNP), Mikumi NP (MKNP), Ngorong-
oro Conservation Area (NCA), Ruaha NP (RNP), Sel-
ous Game Reserve (SGR), SNP, Tarangire NP (TNP), 
Udzungwa NP (UNP), and Issa Valley (Issa), as well as 
Jozani-Chwaka Bay NP–Masingini Forest (JCBNP) on 
Unguja Island, Zanzibar (Figure 1). We investigated the 
following species: olive baboon, yellow baboon (Papio 
cynocephalus), blue monkey (Cercopithecus mitis), red-
tailed monkey (Cercopithecus ascanius), vervet monkey 
(Chlorocebus pygerythrus), Udzungwa red colobus (Pil-
iocolobus gordonorum), Zanzibar red colobus (Pilio-
colobus kirkii), and Ugandan red colobus (Piliocolobus 
tephrosceles). Using FreeCalc (http://epitools.ausvet.
com.au/content.php?page=FreeCalc2), and based on our 
previous study at LMNP (6) that showed a disease preva-
lence of 85%, we calculated a sample size of >4 (expected 
disease prevalence 85%) to 21 (expected disease preva-
lence 25%) per sample site as statistically sufficient to 
demonstrate freedom from T. pallidum infection using 
imperfect tests and allowing for small populations (on-
line Technical Appendix 1, https://wwwnc.cdc.gov/EID/
article/24/6/18-0037-Techapp1.pdf).
Anesthesia and Sampling
We studied the animals in accordance with applicable 
regulations and guidelines (online Technical Appen-
dix 1). The sampling of blood and skin tissue followed 
a standardized protocol that we previously applied for 
baboons (6,11). In brief, the NHPs were chemically im-
mobilized by remote distance injection of 10.0 mg ket-
amine/kg body mass (Kyron Laboratories, Johannesburg, 
South Africa) in combination with 0.2 mg/kg medeto-
midine (Domitor; Pfizer, Berlin, Germany). Anesthet-
ics were intramuscularly injected using a cold-gas im-
mobilization rifle (MOD JM; Dan-Inject ApS, Børkop, 
Figure 1. Protected areas 
and sites where free-ranging 
nonhuman primates (NHPs) 
were sampled in a study of 
Treponema pallidum infection, 
Tanzania. 1, Serengeti National 
Park (41 NHPs); 2, Ngorongoro 
Conservation Area (18 NHPs); 3, 
Lake Manyara National Park (38 
NHPs); 4, Tarangire National Park 
(26 NHPs); 5, Arusha National 
Park (14 NHPs); 6, Gombe 
National Park (32 NHPs); 7, 
Mahale National Park (17 NHPs); 
8, Issa Valley (2 NHPs); 9, Katavi 
National Park (12 NHPs); 10, 
Ruaha National Park (18 NHPs); 
11, Udzungwa National Park 
(25 NHPs); 12, Mikumi National 
Park (25 NHPs); 13, Selous 
Game Reserve (8 NHPs); 14, 
Jozani-Chwaka Bay National 
Park–Masingini Forest on Unguja 
Island, Zanzibar (13 NHPs). 
Dark green indicates national 
parks; light green indicates 
game reserves; yellow indicates 
conservation area. Circle graphs: 
black, NHPs T. pallidum–
positive (serology and/or PCR); 
white, NHPs T. pallidum–negative 
(serology and PCR). The map 
was produced with ArcMap 
version 10.0 (ESRI, Redlands, 
CA, USA) by using shape files 
available from ESRI (national boundary of Tanzania, water bodies of Africa, main rivers of Africa). The shape files of the conservation 
areas of Tanzania were provided by the Tanzania National Park Authority and are available free from http://www.arcgis.com/home/
item.html?id = 9b06fe723ad14991b30b1b85953224c1. Prevalence circles were generated using Excel version 15.38 (Microsoft, 
Redmond, WA, USA).
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Denmark) and appropriate projectiles. Immobilized 
NHPs were continuously observed for vital parameters 
such as respirations, pulse frequency, and internal body 
temperature. We monitored pulse frequency and blood 
oxygen saturation using a Nellcor OxiMax N65 Pulse 
Oximeter (Tyco Healthcare Deutschland GmbH, Neus-
tadt, Germany). Anesthetized animals underwent a stan-
dardized health check with special focus on skin lesions. 
We collected whole blood from the femoral vein using 
an S-Monovette closed blood collection system (Sarstedt, 
Nümbrecht, Germany) mounted with a 20G needle. We 
collected two 9-mL serum tubes under aseptic condi-
tions. We then centrifuged serum tubes at 55,000 rela-
tive centrifugation force for 15 min, transferred serum 
into cryovials, and stored the vials in liquid nitrogen. In 
animals with skin lesions, we took a 6-mm biopsy from 
the skin ulcer using a sterile dermal biopsy punch. From 
each animal (and ulcer), we preserved tissue samples in 
lysis buffer (10 mmol/L Tris [pH 8.0], 0.1 EDTA, and 
0.5% sodium dodecyl sulfate).
We treated animal wounds with Silverspray (Silver 
Aluminum Aerosol; Henry Schein, Langen, Germany) 
and allowed animals to recover under close supervision. 
Samples were temporarily stored at –80°C at the Tan-
zania Wildlife Research Institute headquarters (Arusha, 
Tanzania). Aliquots were exported to the German Primate 
Center (Göttingen, Germany) for further analysis and ad-
ditional confirmation.
Serologic Testing
We used a commercially available treponemal test (ES-
PLINE TP; Fujirebio Diagnostics, Hannover, Germany) 
to check all serum samples for T. pallidum antibodies. 
The assay has been validated for use in baboons (12), 
where it performed with 97.7% (95% CI 87.7%–99.9%) 
sensitivity and 96.0% (95% CI 79.7%–99.9%) specific-
ity. We tested serum samples on the day of sampling and 
operated and interpreted test cassettes according to the 
manufacturer’s guidance.
DNA Extraction from Skin Tissue
We extracted DNA following the standard protocol of the 
QIAmp DNA Mini Kit (QIAGEN, Hilden, Germany), with 
some minor modifications. In brief, we cut ≈25 mg tissue 
into small pieces and incubated in 180 µL lysis buffer, in 
which the sample had been stored since collection. After 
adding 20 µL proteinase K, samples were digested over-
night at 56°C and 900 rpm (Thermomixer Comfort; Eppen-
dorf, Hamburg, Germany). We added an additional wash-
ing step using 300 µL AW1 buffer and eluted the DNA 
twice with 100 µL AE buffer. We further purified extracted 
DNA using glycogen precipitation according to the proto-
col published in Knauf et al. (13).
TP_0105 (polA) Amplification and Sequencing
We performed PCR targeting the polymerase 1 gene 
(TP_0105, polA) of T. pallidum by using primers de-
signed by Liu et al. (14). This assay has a reported sen-
sitivity of 95.8% and a specificity of 95.7% and has been 
demonstrated to segregate pathogenic T. pallidum subspe-
cies from nonpathogenic treponemes, other spirochetes, 
and 59 species of bacteria and viruses including those 
causing genital ulcers in humans (14). The 50-µL reac-
tion volume comprised 25 µL 2 × Universe High-Fidelity 
Hot Start DNA Polymerase Master Mix (Biotool, Munich, 
Germany), 17 µL RNAase free water, 2 µL of each 10 
µmol/L primer, 1 µL DNA polymerase (1 U/µL), 1 µL 
of 10 mmol/L each dNTP, and 2 µL template DNA, in-
dependent of DNA concentration. We conducted ampli-
fication in a SensoQuest Labcycler using the following 
thermocycling conditions: predenaturation at 95°C for 3 
min, followed by 50 cycles each with 95°C for 15 s, 60°C 
for 15 s, and 72°C for 30 s. The profile was completed 
with a postextension step at 72°C for 5 min and indefi-
nite cooling of the PCR product at 8°C. All polA PCR 
products were run on a 1% agarose gel to check for PCR 
performance and correct amplicon size. We gel extracted 
a representative subset of the PCR products (n = 19), pu-
rified with the QIAGEN Gel Extraction Kit (QIAGEN), 
and Sanger sequenced using the BigDye Terminator 
Cycle Sequencing Kit (Applied Biosystems, Foster City, 
CA, USA) and the amplification primers. Sequencing was 
performed by Seqlab Sequence Laboratories (Microsynth, 
Göttingen, Germany).
TP_0574 (tp47) Quantitative PCR
We performed TaqMan real-time PCR targeting a 132-bp 
fragment of the TP_0574 gene. Primers and probe used were 
published elsewhere (15). The reaction encompassed 10 µL 
TaqMan Universal MasterMix II (no Uracil-N glycosylase; 
Applied Biosystems) and 1.8 µL of each 10 µmol/L primer 
and the probe. Total genomic DNA concentration added to 
each reaction was normalized to 100 ng. Molecular-grade 
water was used to adjust the reaction volume to 20 µL. Cy-
cling conditions were as follows: 50°C for 2 min, 95°C for 
10 min, followed by 50 cycles each at 95°C for 15 s and 
60°C for 60 s. Reactions were run on a StepOnePlus Real-
Time PCR System (Applied Biosystems). We measured all 
samples as triplicates and analyzed data using StepOne ver-
sion 2.3 software (Applied Biosystems).
TP_0619 Amplification and Sequencing
We performed PCR targeting the TP_0619 gene of T. palli-
dum to distinguish infection with TPE or T. pallidum subsp. 
endemicum (TEN) strains from infection with T. pallidum 
subsp. pallidum (TPA) strains. At this locus, TPA differs 
from TPE and TEN in >73 positions (online Technical 
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Appendix 1 Figure). We used primers 5′-TTACCCAGA-
CATTTTTCTCCACATA-3′ and 5′-TACAAGCTCCCA-
CAATGCCA-3′ to amplify a 608-bp fragment. The PCR 
conditions and working steps were identical to the PCR tar-
geting the polA gene, except that the annealing temperature 
was adjusted to 55°C.
Data Analysis
We performed statistical analyses using GraphPad Prism 
version 7.0c (GraphPad Software, La Jolla, CA, USA), 
and R version 3.3.2 (R Foundation for Statistical Comput-
ing, Vienna, Austria). We compared variables such as the 
presence of T. pallidum antibodies and clinical manifesta-
tions per species by using 2 × 2 × n contingency tables and 
a 2-tailed Fisher exact test. We used a χ2 test to compare 
the outcome of >2 sampling sites using n × 2 contingency 
tables. Proportions were tested at a critical probability of 
0.05 and 95% CI. We considered p<0.05 as statistically 
significant.
We analyzed and edited retrieved sequence data 
using 4Peaks 1.8 (http://www.nucleobytes.com) and 
SeaView 4.5.4 software (16). We compared sequences 
with respective orthologs available in GenBank using a 
standard nucleotide BLAST search (http://blast.ncbi.nlm.
nih.gov/Blast.cgi).
Results
NHP Species
We sampled 289 NHPs (Table) and confirmed previ-
ously reported T. pallidum infection in olive baboons at 
GNP (5,17,18), SNP (3), NCA (3), and LMNP (3,6,7). In 
addition, we report T. pallidum infection in yellow ba-
boons, vervet monkeys, and blue monkeys in different 
regions of Tanzania (Table; Figure 1; online Technical 
Appendix 2, https://wwwnc.cdc.gov/EID/article/24/6/ 
18-0037-Techapp2.xlsx).
The overall mean seropositivity of T. pallidum infec-
tion in the NHP samples was 53.3% (154/289). More fe-
male (82/135 [60.7%]) than male (72/154 [46.8%]) NHPs 
had T. pallidum antibodies. Overall, 35/45 (77.8%) vervet 
monkeys, 85/137 (62.0%) olive baboons, 33/75 (44.0%) 
yellow baboons and 1/15 (6.7%) blue monkeys had anti-
bodies against the bacterium. Most (94 [61.0%]) of the 154 
seropositive NHPs appeared healthy without any clinical 
skin lesions. The association between T. pallidum antibod-
ies and skin ulceration was tested using 2-tailed Fisher 
exact test and was significant in olive baboons (n = 137; 
odds ratio [OR] 15.95 [95% CI 4.7–51.1]; p<0.0001) and 
yellow baboons (n = 75; OR 11.04 [95% CI 1.7–126.8]; p 
= 0.0185), but not in vervet (n = 45; OR ∞ [95% CI 0.0–
1.0]; p = 0.0888) and blue monkeys (n = 15; OR 0.00 [95% 
CI 0.0–126.0]; p>0.9999 [dataset is provided in online 
Technical Appendix 2]). No T. pallidum antibodies were 
detected in the 10 Zanzibar red colobus, 3 Udzungwa red 
colobus, 2 Ugandan red colobus, and 2 red-tailed monkeys 
sampled. Moreover, none of these 4 species showed any 
kind of skin ulceration (Table).
Clinical Manifestations
Among the 156 T. pallidum–seropositive and/or PCR-
positive NHPs (including 2 serologically negative but 
PCR-positive animals) and across the different sampling 
sites, we found anogenital ulcers associated with the in-
fection (Figure 2, panel A) in 59.8% ± 23.9% of the yel-
low baboons (mean ± SEM, 6 investigated sites; data were 
analyzed as fraction of T. pallidum–infected animals with 
anogenital lesions per sampling site); 45.6% ± 16.2% of 
the olive baboons (mean ± SEM, 6 investigated sites); and 
31.6% ± 9.4% of the infected vervet monkeys (mean ± 
SEM, 9 investigated sites). One of the 2 T. pallidum–in-
fected blue monkeys showed anogenital skin ulceration; 
the second animal was clinically healthy. Orofacial le-
sions (Figure 2, panel B) were exclusively observed in 
 
Table. Test results of Treponema pallidum infection in samples of free-ranging nonhuman primate species, Tanzania* 
Species No. (%) 
Total/seropositive/skin lesion/PCR positive† 
Positive 
 
Negative 
Total Male Female Total Male Female 
Olive baboon (Papio anubis) 137 (47.4) 86 34/34/12/12 52/51/31/30‡  51 29/0/1‡/NA 22/0/1‡/NA 
Yellow baboon (Papio cynocephalus) 75 (26.0) 33 17/17/2/2 16/16/5/5  42 27/0/1§/NA 15/0/0/NA 
Vervet monkey (Chlorocebus pygerythrus) 45 (15.6) 35 21/21/10/8‡ 14/14/1/1  10 7/0/0/NA 3/0/0/NA 
Blue monkey (Cercopithecus mitis) 15 (5.2) 2 1/0/1/1 1/1/0/0  13 8/0/0/NA 5/0/0/NA 
Red-tailed monkey (Cercopithecus ascanius) 2 (0.7) 0 NA NA  2 2/0/0/NA NA 
Zanzibar red colobus (Piliocolobus kirkii) 10 (3.5) 0 NA NA  10 4/0/0/NA 6/0/0/NA 
Udzungwa red colobus (Piliocolobus 
gordonorum) 
3 (1.0) 0 NA NA  3 2/0/0/NA 1/0/0/NA 
Ugandan red colobus (Piliocolobus 
tephrosceles) 
2 (0.7) 0 0/0/0/0 0/0/0/0  2 2/0/0/NA NA 
Total 289 (100.0) 156 73 83  133 81 52 
*Results are based on the consensus of detected T. pallidum antibodies (ESPLINE TP) and PCR results of 3 independent gene targets (polA, tp47, and 
TP_0619). NA, not applicable. 
†PCR was conducted only on animals with skin lesions. 
‡No skin sample was available for some positive animals. 
§Skin lesion at the genitalia most likely from fight; no tissue sample available. 
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olive baboons at SNP, TNP, and LMNP, of which 2 olive 
baboons at TNP and 1 at SNP were included in our study. 
These animals represent 3.5% of the 86 T. pallidum–sero-
positive and/or PCR-positive sampled olive baboons. One 
animal from TNP had concurrent orofacial and anogenital 
skin ulcerations. We also observed these ulcerations in ol-
ive baboons at LMNP, although capture and sampling of 
these animals was not possible.
Geographic Distribution
Our results provide evidence for T. pallidum infection in 
NHPs at 11 of the 14 sites investigated (Figure 1; online 
Technical Appendix 2). The only sites where infection was 
not detected were ANP (14 NHPs), SGR (9 NHPs), and 
JCBNP (13 NHPs). We found T. pallidum–positive vervet 
monkeys in all areas where the species was examined (GNP, 
KNP, LMNP, MKNP, MNP, RNP, SNP, TNP, UNP) ex-
cept for the 1 animal from Zanzibar (JCBNP). One PCR-
positive and anogenital ulcerated blue monkey from LMNP 
had reproducibly negative serologic results. Because sam-
pling was biased toward animals with skin lesions, we more 
objectively compared field sites by analyzing data from 
animals that appeared to be clinically unaffected. Healthy-
looking olive baboons were significantly more often T. pal-
lidum–positive at LMNP (n = 6/6) than at any other sam-
pling area in Tanzania where the species is present (ANP 
[n = 0/12], GNP [n = 8/23], NCA [1/9], SNP [n = 16/25], 
TNP [n = 12/17]; 6 × 2 contingency table: χ2 = 30.15, df = 5; 
p<0.0001). Likewise, clinically unaffected yellow baboons 
were significantly more often T. pallidum–infected at MKNP 
(n = 16/19) than at any of the other sampling areas in Tanza-
nia where the species is present (KNP [n = 0/6], MNP [n = 
0/10], RNP [n = 8/16], SGR [n = 0/7], UNP [n = 2/17]; 6 × 2 
contingency table: χ2 = 38.39, df = 5; p<0.0001). In the ver-
vet monkeys, we found no differences among sampling sites 
(GNP [n = 3/3], KNP [n = 2/5], LMNP [n = 1/2], MKNP [n 
= 2/3], MNP [n = 1/2], RNP [n = 4/4], SNP [n = 8/8], TNP [n 
= 3/6], JCBNP [n = 0/1]; 9 × 2 contingency table: χ2 = 12.97, 
df = 8; p = 0.1130), but sample size per site was low (online 
Technical Appendix 2).
Molecular Characterization of T. pallidum Samples
In the 65 animals with skin ulcers, we confirmed T. pal-
lidum by amplification of a part of the polA gene (classic 
PCR) and/or the tp47 locus (quantitative PCR; 59/60 ani-
mals tested positive; online Technical Appendix 2). For 5 
animals, we did not perform PCR because of limited quanti-
ties of samples. All obtained sequences were identical. We 
deposited a representative sequence of the polA gene from 
a yellow baboon (16RUF8140716) in GenBank (accession 
no. MF627733). Of 58 tested animals, 56 were positive in 
the PCR targeting the TP_0619 locus. For 7 NHPs, no PCR 
was performed because of sample limitations. Again, all 41 
sequences obtained were identical. We deposited a repre-
sentative sequence from a vervet monkey (4KNF2121016) 
in GenBank (accession no. MF754122). The haplotype was 
identical to those derived from TPE and TEN strains but 
different from TPA strains in >73 positions (online Techni-
cal Appendix 1 Figure).
Discussion
We confirmed T. pallidum infection in 4 free-ranging NHP 
species at 11 of 14 investigated sites in Tanzania. Our data 
for GNP must be interpreted with caution. GNP has a his-
tory of treating infected baboons with antimicrobial drugs 
(17), which might have affected prevalence rates and clin-
ical manifestations. The finding that clinically unaffected 
olive baboons at LMNP, but also many animals at SNP 
and TNP, were infected with the bacterium (as indicated 
by serology; Table) shows that clinical manifestations are 
not representative of the actual prevalence of the disease. 
This finding is consistent with reports from an earlier 
Figure 2. Treponema pallidum–induced clinical manifestations 
affecting olive baboons (Papio anubis), Tanzania. A). Lesions 
on the anogenital area of animal at Lake Manyara National 
Park. B) Facial lesions of animal at Tarangire National Park. 
Orofacial lesions were found only in olive baboonsA color version 
of this figure is available online (http://wwwnc.cdc.gov/EID/
article/24/6/18-0037-F2.htm).
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investigation of olive baboons at LMNP in 2007 (6) and 
in Guinea baboons (Papio papio) in the Niokolo Koba 
National Park, Senegal (11). In the context of human T. 
pallidum infection, where a latent stage is a key feature of 
infection (19) and which equally features positive serol-
ogy in the absence of active skin lesions (20), this finding 
could argue for a similarity of disease progression in the 
NHP host. However, in the absence of long-term monitor-
ing data for infected NHPs, relapsing cases, which would 
indicate the latent stage, cannot be identified, and stan-
dardized laboratory infection might be needed to obtain 
those data.
Although reduced susceptibility for T. pallidum infec-
tion is possible in some of the investigated species (colo-
bines), it is likely that infection is not yet present because 
of behavioral and ecologic constraints between the infected 
and noninfected species. At least in a recent publication, 
a Ugandan red colobus was described with suspected ac-
tive yaws-like lesions in Uganda (21). Consequently, we 
note that our sample size for colobines and red-tailed mon-
keys was insufficient. As a result, a conclusive evaluation 
on possible T. pallidum infection in these species was not 
possible. The same applied for sites where the number of 
infected NHPs was critically low, for example, UNP and 
MNP or the negative tested areas at ANP (14 animals), 
SGR (9 animals), and JCBNP (13 animals), as well as the 
NCA crater region where all 8 olive baboons were tested 
negative. We found T. pallidum–infected vervet monkeys 
with and without skin ulcers in 9 of the 10 sites where the 
species has been investigated. This finding and the larger 
number and geographic extent of T. pallidum infection in 
Chlorocebus sp. (4,11,22–24) deserve further attention in 
prospective studies, especially in areas where the species is 
present but has not yet been tested.
All T. pallidum–positive NHPs in this study revealed a 
TP_0619 sequence that points toward infection with either 
TPE or TEN strains (online Technical Appendix 1 Figure). 
In the context of the geographic distribution of TEN strains 
(dry areas in Sahelian Africa and western Asia) (25) as 
well as the information obtained from the whole-genome 
sequences of the Tanzanian simian strains LMNP1 and 2 
(S. Knauf et al., unpub. data, https://www.biorxiv.org/con-
tent/early/2017/05/10/135491), which are considered TPE 
strains, we assume that TPE is the dominant, if not exclu-
sive, T. pallidum subspecies infecting Tanzanian NHPs. 
Further clarification will be achieved when multilocus 
strain typing data and whole-genome sequence data of the 
NHP samples become available.
In humans, TPE is mainly transmitted by direct skin-
to-skin contact (26). A possible important alternate route 
of infection has been discussed through the involvement 
of flies as a vector (27,28). Although both options are at 
least theoretically possible for NHPs (13), direct contact 
should be considered the most likely way of intraspe-
cies and interspecies transmission. Such transmission is 
further supported by reports of the close association and 
interaction (play, fight, or hunt) among different NHP spe-
cies (29–31). Again, multilocus strain typing and whole-
genome sequence data of the strains infecting NHPs in 
Tanzania are likely to contribute to a better understanding 
of host–pathogen coevolution and will provide details of 
the relatedness of the T. pallidum subspecies that infect the 
different NHP taxa.
Human yaws is known to be endemic to 13 countries, 
but Tanzania is among the 76 countries with a known his-
tory of the disease that lack recent epidemiologic data (2). 
More precisely, the disease was reported to be endemic 
in humans in the western areas along Lake Tanganyika 
and in southern Tanzania (32). Extensive elimination ef-
forts decreased the reported incidence of human yaws in 
Tanzania from 120,000 cases in 1927 to 52,000 in 1950 
(33) and 71 in 1978 (https://web.gideononline.com). At 
the same time, the wide distribution of T. pallidum infec-
tion in NHP on Tanzania’s mainland (7) and the chronic 
infection with locally high prevalence rates (e.g., LMNP 
[6]) suggest the pathogen has been present in the respec-
tive NHP populations for at least several decades. How-
ever, current data are insufficient to develop a conclusive 
biogeographic scenario about the origin and spread of the 
infection. The first published report on T. pallidum infec-
tion in NHPs in 1989 (5) involved olive baboons at GNP. 
Although this is no evidence for the origin of T. pallidum 
infection in NHPs in Tanzania, it is interesting in the con-
text of a possible anthropozoonotic introduction of the 
disease. GNP is in the region that has been historically 
classified as an area to which human yaws in Tanzania is 
endemic (33). Furthermore, GNP is close to the Demo-
cratic Republic of the Congo, a country that still reports 
cases of human yaws (34). However, all of this is specula-
tive, and whole-genome data are needed from NHPs and 
human strains from the same area to provide a deeper un-
derstanding on the origin and transmission of T. pallidum 
in NHPs in Tanzania.
In a larger context, neighboring countries currently 
do not report NHPs with T. pallidum–confirmed skin le-
sions, although animals from East Africa (not further clas-
sified) (22) and Kenya (3) have tested serologically posi-
tive. Because T. pallidum infection in NHPs in Africa is 
widespread (1), further investigations should specifically 
include more East Africa countries, particularly those that 
share their borders with Tanzania.
We showed that T. pallidum infection in NHPs in Tan-
zania is geographically widespread and present in several 
Old World monkey species, namely olive and yellow ba-
boons, vervet monkeys, and blue monkeys (hypothesis A). 
We identified the pathogen in almost all investigated sites 
covering large parts of Tanzania’s mainland (hypothesis B) 
and showed that NHPs in Tanzania are most likely infected 
by TPE strains. Nevertheless, our overall sample size does 
not permit a conclusive statement on T. pallidum prevalence 
in NHPs at any of the sampled sites. Further studies on the 
spatial distribution of NHP infection with T. pallidum and 
advanced genetic characterization of simian strains are cru-
cial for identifying NHPs as a possible reservoir for human 
infection (35). In light of the data and for a sustainable eradi-
cation of human yaws, a One Health approach in which ani-
mal and human health is investigated (36) is needed.
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